Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 520 entries
View as:

Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)

Phase: N/A Priority: Normal
NCT ID: NCT00617591 Org: User:
Start: 01/31/08 End: 04/30/13 Due: 04/30/14

Single Agent Regorafenib in Refractory Advanced Biliary Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02115542 Org: User:
Start: 06/05/14 End: 09/20/21 Due: 09/20/22

Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia

Phase: N/A Priority: Normal
NCT ID: NCT00596011 Org: User:
Start: 11/14/07 End: 07/27/18 Due: 07/27/19

Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study

Phase: N/A Priority: Normal
NCT ID: NCT02803333 Org: User:
Start: 02/16/17 End: 11/19/21 Due: 11/19/22

Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06691035 Org: User:
Start: 11/04/24 End: 11/30/27 Due: 11/30/28

Exercise Prehabilitation for Locoregional Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06430346 Org: User:
Start: 05/21/24 End: 05/31/27 Due: 05/31/28

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT06121180 Org: User:
Start: 11/04/24 End: 10/31/30 Due: 10/31/31

Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT01422993 Org: User:
Start: 07/31/11 End: 12/31/16 Due: 12/31/17

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00005792 Org: User:
Start: 06/02/98 End: 11/01/18 Due: 11/01/19

Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)

Phase: N/A Priority: Normal
NCT ID: NCT03406715 Org: User:
Start: 03/15/18 End: 05/16/22 Due: 05/16/23

Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX

Phase: N/A Priority: Normal
NCT ID: NCT00360685 Org: User:
Start: 09/30/05 End: 01/31/11 Due: 01/31/12

GTX-RT in Borderline Resectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01754623 Org: User:
Start: 02/28/13 End: 10/31/14 Due: 10/31/15

Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance

Phase: N/A Priority: Normal
NCT ID: NCT04101526 Org: User:
Start: 08/15/19 End: 04/09/21 Due: 04/09/22

Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma

Phase: N/A Priority: Normal
NCT ID: NCT03927274 Org: User:
Start: 06/20/19 End: 05/24/23 Due: 05/24/24

Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT05127174 Org: User:
Start: 03/14/22 End: 01/03/25 Due: 01/03/26

Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center

Phase: N/A Priority: Normal
NCT ID: NCT06712797 Org: User:
Start: 02/19/25 End: 11/30/27 Due: 11/30/28

Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06909357 Org: User:
Start: 03/28/25 End: 03/31/26 Due: 03/31/27

Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers

Phase: N/A Priority: Normal
NCT ID: NCT03598309 Org: User:
Start: 06/05/19 End: 05/31/26 Due: 05/31/27

Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01606345 Org: User:
Start: 07/31/12 End: 04/30/16 Due: 04/30/17

Liposuction for Arm Lymphedema Following Breast Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00816985 Org: User:
Start: 12/03/08 End: 06/22/21 Due: 06/22/22

Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00101101 Org: User:
Start: 07/31/04 End: 06/14/21 Due: 06/14/22

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Phase: N/A Priority: Normal
NCT ID: NCT02336984 Org: User:
Start: 06/30/14 End: 04/04/16 Due: 04/04/17

Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00499109 Org: User:
Start: 05/31/07 End: 11/30/13 Due: 11/30/14

Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT03663166 Org: User:
Start: 11/20/18 End: 10/22/21 Due: 10/22/22

Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05681780 Org: User:
Start: 03/10/23 End: 12/31/27 Due: 12/31/28